MIPS Home MIPS General Information MIPS Grants MIPS Courses MIPS Research MIPS Software MIPS Web Tools MIPS Sitemap
About MIPS MIPS News Faculty & Staff Recent Pubs Directions Facilities Events & Meetings Employment Associated Depts Useful Links
Grant News CCNE-TR CVIS ICMIC ICBP NTROI SMIS
BIOE222 Pharmacokinetics Stats & Data Analysis
BIOE222A F2009 BIOE222B W2009 BIOE222A F2008 BIOE222B W2008 BIOE222A F2007 BIOE222B W2007 BIOE222 F2006 BIOE222 F2005 BIOE222 F2004
Biswal Lab Blankenberg Lab Cheng Lab Contag Lab Felsher Lab Gambhir Lab Graves Lab Guccione Lab Levin Lab Lin Lab McConnell Moseley Lab Paik Lab Plevritis Lab Ramasamy Lab Rao Lab Rutt Lab Schnitzer Lab Vasanawala Lab Willmann Lab Wu Lab Xing Lab
NCIL MRSRL
AMIDE
NucMed Mediabook PET Brain Atlas PET-FDG Whole Body Atlas




CCNE Home

Nanobiotechnology Seminar

Annual Symposium

CCNE News

Faculty

Postdocs
Graduate Students

Scientific Papers

Corporate Collaboration

Private Foundations

Projects

Core Resources

Pilot Projects

Leadership & Organization

Environment

Links

Employment Opportunities


Center for Cancer Nanotechnology Excellence Focused on Therapy Response

Faculty

Samira Guccione, Ph.D.
Investigator: Core 3
Assistant Professor of Radiology
Lucas MRSI Center
1201 Welch Rd, Rm P274
Stanford, California, 94305-5488
Phone: (650) 725-4936
Fax: (650) 723-5795
Email: samira.guccione@stanford.edu


Investigator: Core 3, Assistant Professor of Radiology (Stanford)
Dr. Guccione is an Assistant Professor of Radiology at Stanford and a member of the MIPS. Her research interests include the development of imaging and therapeutic agents targeting the vasculature. She uses high throughput genomic and proteomic analysis to evaluate potential targets for imaging and therapy. Her work includes development of a nanoparticle-based molecular imaging probe that targets the integrins on the luminal side of the endothelium. These nanoparticles have been used to image tumor vasculature in models for brain (glioblastoma multiforme), melanoma, and colon metastasis to the liver and lung. A modified form of these nanoparticles has been used for gene delivery to the tumor vasculature. This anti-angiogenic therapy is being developed for clinical trials. Other areas of interest include stem cells, drug and gene delivery, radiation sensitizers, and the use of ultrasound for imaging and delivery of therapeutics.

[ Back ]
crumpnews events